| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 39 |
| 1 | ASPIRIN 325 MG | 37 |
| 2 | ASPIRIN 81 MG | 37 |
| 3 | INTERFERON BETA-1A | 35 |
| 4 | CLOPIDOGREL | 31 |
| 5 | ADALIMUMAB | 30 |
| 6 | RIVAROXABAN | 27 |
| 7 | PREDNISOLONE | 25 |
| 8 | PREDNISOLONE ORAL | 25 |
| 9 | PREDNISOLONE ORAL SOLUTION | 25 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EDOXABAN TOSYLATE | 5 | 0.0007 |
| 1 | ROMOSOZUMAB-AQQG | 8 | 0.0006 |
| 2 | EXTENDED PHENYTOIN SODIUM | 6 | 0.0004 |
| 3 | SILDENAFIL POWDER, | 10 | 0.0003 |
| 4 | IBUPROFEN AND DIPHENHYDRAMINE CITRATE | 5 | 0.0002 |
| 5 | INTERFERON BETA-1A | 35 | 0.0002 |
| 6 | ETHYL ALCOHOL | 5 | 0.0002 |
| 7 | CLOPIDOGREL BISULFATE | 17 | 0.0002 |
| 8 | CLOPIDOGREL | 31 | 0.0002 |
| 9 | ISOPROPYL ALCOHOL | 5 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 81 |
| 1 | Corticosteroid [EPC] | 56 |
| 2 | Factor Xa Inhibitor [EPC] | 50 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 40 |
| 4 | Interferon beta [EPC] | 35 |
| 5 | Proton Pump Inhibitor [EPC] | 31 |
| 6 | Benzodiazepine [EPC] | 29 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 26 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 23 |
| 9 | Angiotensin 2 Receptor Blocker [EPC] | 21 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anti-coagulant [EPC] | 4 | 0.0011 |
| 1 | Photoenhancer [EPC] | 3 | 0.0008 |
| 2 | Humanized Monoclonal Antibody Fragment [EPC] | 1 | 0.0007 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 4 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |
| 5 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 6 | Osmotic Diuretic [EPC] | 2 | 0.0004 |
| 7 | Monobactam Antibacterial [EPC] | 1 | 0.0004 |
| 8 | Calcitonin [EPC] | 1 | 0.0003 |
| 9 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 2 | 0.0003 |